INTELLIPHARMACEUTICS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INTELLIPHARMACEUTICS, and what generic and branded alternatives to INTELLIPHARMACEUTICS drugs are available?
INTELLIPHARMACEUTICS has five approved drugs.
Drugs and US Patents for INTELLIPHARMACEUTICS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intellipharmaceutics | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204805-001 | May 7, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Intellipharmaceutics | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 202939-004 | May 9, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Intellipharmaceutics | DEXMETHYLPHENIDATE HYDROCHLORIDE | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 078992-004 | Nov 18, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Intellipharmaceutics | DEXMETHYLPHENIDATE HYDROCHLORIDE | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 078992-005 | Nov 23, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Intellipharmaceutics | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201272-002 | Nov 23, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.